HK1079519A1 - Furyl compounds - Google Patents
Furyl compoundsInfo
- Publication number
- HK1079519A1 HK1079519A1 HK05111483A HK05111483A HK1079519A1 HK 1079519 A1 HK1079519 A1 HK 1079519A1 HK 05111483 A HK05111483 A HK 05111483A HK 05111483 A HK05111483 A HK 05111483A HK 1079519 A1 HK1079519 A1 HK 1079519A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- compounds
- furyl compounds
- furyl
- compositions
- therapy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Saccharide Compounds (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0201186A SE0201186D0 (sv) | 2002-04-18 | 2002-04-18 | Furyl compounds |
SE0203607A SE0203607D0 (sv) | 2002-12-04 | 2002-12-04 | Furyl compounds |
PCT/SE2003/000613 WO2003087102A1 (en) | 2002-04-18 | 2003-04-15 | Furyl compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1079519A1 true HK1079519A1 (en) | 2006-04-07 |
Family
ID=29253788
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK05111483A HK1079519A1 (en) | 2002-04-18 | 2005-12-14 | Furyl compounds |
Country Status (16)
Country | Link |
---|---|
US (1) | US7417049B2 (no) |
EP (1) | EP1499618B1 (no) |
JP (1) | JP4511195B2 (no) |
KR (1) | KR20040099447A (no) |
CN (1) | CN1325500C (no) |
AT (1) | ATE484508T1 (no) |
AU (1) | AU2003225456B2 (no) |
BR (1) | BR0309343A (no) |
CA (1) | CA2482311C (no) |
DE (1) | DE60334536D1 (no) |
HK (1) | HK1079519A1 (no) |
IL (1) | IL164509A0 (no) |
MX (1) | MXPA04010191A (no) |
NO (1) | NO20044996L (no) |
NZ (1) | NZ561794A (no) |
WO (1) | WO2003087102A1 (no) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR036040A1 (es) | 2001-06-12 | 2004-08-04 | Upjohn Co | Compuestos de heteroarilo multiciclicos sustituidos con quinuclidinas y composiciones farmaceuticas que los contienen |
DK1432707T3 (da) | 2001-10-02 | 2012-06-11 | Pharmacia & Upjohn Co Llc | Azabicyklisk-substituerede kondenserede heteroarylforbindelser til behandling af sygdomme |
DE10164139A1 (de) | 2001-12-27 | 2003-07-10 | Bayer Ag | 2-Heteroarylcarbonsäureamide |
NZ535978A (en) * | 2002-04-18 | 2007-10-26 | Astrazeneca Ab | Novel spiroazabicyclic heterocyclic amines useful as nicotinic acetylcholine receptor agonists |
CA2543436A1 (en) * | 2003-10-21 | 2005-05-12 | Astrazeneca Ab | Spirofuropyridine aryl derivatives |
US7045530B2 (en) | 2003-12-22 | 2006-05-16 | Abbott Laboratories | Spirocyclic quinuclidinic ether derivatives |
TW200813067A (en) | 2006-05-17 | 2008-03-16 | Astrazeneca Ab | Nicotinic acetylcholine receptor ligands |
SA08290475B1 (ar) | 2007-08-02 | 2013-06-22 | Targacept Inc | (2s، 3r)-n-(2-((3-بيردينيل)ميثيل)-1-آزا بيسيكلو[2، 2، 2]أوكت-3-يل)بنزو فيوران-2-كربوكساميد، وصور أملاحه الجديدة وطرق استخدامه |
EA201001889A1 (ru) | 2008-06-20 | 2011-08-30 | Астразенека Аб | Производные дибензотиазепина и их применение |
TW201031664A (en) | 2009-01-26 | 2010-09-01 | Targacept Inc | Preparation and therapeutic applications of (2S,3R)-N-2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)-3,5-difluorobenzamide |
RS56812B1 (sr) | 2010-05-17 | 2018-04-30 | Forum Pharmaceuticals Inc | Farmaceutske formulacije koje sadrže kristalne oblike (r)-7-hloro-n-(kinuklidin-3-il)benzo(b)tiofen-2-karboksamid hidrohlorid monohidrata |
EP2576496B1 (en) * | 2010-05-27 | 2017-03-08 | Catalyst Biosciences, Inc. | Nicotinic receptor non-competitive antagonists |
GB201111704D0 (en) | 2011-07-07 | 2011-08-24 | Takeda Pharmaceutical | Novel compounds |
GB201111705D0 (en) | 2011-07-07 | 2011-08-24 | Takeda Pharmaceutical | Compounds and their use |
JO3115B1 (ar) | 2011-08-22 | 2017-09-20 | Takeda Pharmaceuticals Co | مركبات بيريدازينون واستخدامها كمثبطات daao |
WO2013169646A1 (en) | 2012-05-08 | 2013-11-14 | Envivo Pharmaceuticals, Inc. | Methods of maintaining, treating or improving cognitive function |
GB201209587D0 (en) | 2012-05-30 | 2012-07-11 | Takeda Pharmaceutical | Therapeutic compounds |
JP6478923B2 (ja) | 2013-02-07 | 2019-03-06 | ヘプタレス セラピューティクス リミテッドHeptares Therapeutics Limited | ムスカリンm4受容体アゴニストとしてのピペリジン−1−イル及びアゼピン−1−イルカルボキシレート |
AU2014282977B2 (en) | 2013-06-21 | 2018-06-14 | Takeda Pharmaceutical Company Limited | 1-sulfonyl piperidine derivatives as modulators of prokineticin receptors |
GB201314286D0 (en) | 2013-08-08 | 2013-09-25 | Takeda Pharmaceutical | Therapeutic Compounds |
GB201318222D0 (en) | 2013-10-15 | 2013-11-27 | Takeda Pharmaceutical | Novel compounds |
GB201320905D0 (en) | 2013-11-27 | 2014-01-08 | Takeda Pharmaceutical | Therapeutic compounds |
TW201613864A (en) | 2014-02-20 | 2016-04-16 | Takeda Pharmaceutical | Novel compounds |
EP3215512A1 (en) | 2014-11-04 | 2017-09-13 | Bristol-Myers Squibb Company | Quinuclidine compounds as alpha-7 nicotinic acetylcholine receptor ligands |
GB201616839D0 (en) | 2016-10-04 | 2016-11-16 | Takeda Pharmaceutical Company Limited | Therapeutic compounds |
CN108018049B (zh) * | 2016-10-28 | 2019-09-27 | 西安近代化学研究所 | 具有5,6-二氟取代苯并呋喃环的液晶化合物 |
CN108003895B (zh) * | 2016-10-28 | 2019-04-19 | 西安近代化学研究所 | 一种向列相液晶组合物及其显示元件 |
GB201619514D0 (en) | 2016-11-18 | 2017-01-04 | Takeda Pharmaceuticals Co | Novel compounds |
KR20210005176A (ko) | 2018-05-10 | 2021-01-13 | 조에티스 서비시즈 엘엘씨 | 내부기생충성 뎁시펩타이드 |
JP2021138648A (ja) | 2020-03-04 | 2021-09-16 | 武田薬品工業株式会社 | 経口固形製剤 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR013184A1 (es) * | 1997-07-18 | 2000-12-13 | Astrazeneca Ab | Aminas heterociclicas espiroazobiciclicas, composicion farmaceutica, uso de dichas aminas para preparar medicamentos y metodo de tratamiento o profilaxis |
SE9900100D0 (sv) * | 1999-01-15 | 1999-01-15 | Astra Ab | New compounds |
FR2788982B1 (fr) | 1999-02-02 | 2002-08-02 | Synthelabo | Compositions pharmaceutiques contenant de la nicotine et leur application dans le sevrage tabagique |
SI1397366T1 (sl) * | 2001-06-01 | 2007-06-30 | Astrazeneca Ab | Nov ligand za nikotinske acetilholinske receptorje, koristen v terapiji |
US6569865B2 (en) | 2001-06-01 | 2003-05-27 | Astrazeneca Ab | Spiro 1-azabicyclo[2.2.2]octane-3,2′(3′h)-furo[2,3-b]pyridine |
NZ535978A (en) * | 2002-04-18 | 2007-10-26 | Astrazeneca Ab | Novel spiroazabicyclic heterocyclic amines useful as nicotinic acetylcholine receptor agonists |
-
2003
- 2003-04-15 DE DE60334536T patent/DE60334536D1/de not_active Expired - Lifetime
- 2003-04-15 US US10/511,535 patent/US7417049B2/en not_active Expired - Fee Related
- 2003-04-15 CA CA002482311A patent/CA2482311C/en not_active Expired - Fee Related
- 2003-04-15 JP JP2003584058A patent/JP4511195B2/ja not_active Expired - Fee Related
- 2003-04-15 KR KR10-2004-7016547A patent/KR20040099447A/ko not_active Application Discontinuation
- 2003-04-15 BR BR0309343-3A patent/BR0309343A/pt not_active IP Right Cessation
- 2003-04-15 EP EP03746523A patent/EP1499618B1/en not_active Expired - Lifetime
- 2003-04-15 WO PCT/SE2003/000613 patent/WO2003087102A1/en active Application Filing
- 2003-04-15 CN CNB038138956A patent/CN1325500C/zh not_active Expired - Fee Related
- 2003-04-15 MX MXPA04010191A patent/MXPA04010191A/es active IP Right Grant
- 2003-04-15 NZ NZ561794A patent/NZ561794A/en unknown
- 2003-04-15 AT AT03746523T patent/ATE484508T1/de not_active IP Right Cessation
- 2003-04-15 AU AU2003225456A patent/AU2003225456B2/en not_active Ceased
-
2004
- 2004-10-11 IL IL16450904A patent/IL164509A0/xx unknown
- 2004-11-17 NO NO20044996A patent/NO20044996L/no unknown
-
2005
- 2005-12-14 HK HK05111483A patent/HK1079519A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
JP2005533012A (ja) | 2005-11-04 |
DE60334536D1 (de) | 2010-11-25 |
AU2003225456A1 (en) | 2003-10-27 |
KR20040099447A (ko) | 2004-11-26 |
CN1325500C (zh) | 2007-07-11 |
NZ561794A (en) | 2008-11-28 |
CN1662541A (zh) | 2005-08-31 |
JP4511195B2 (ja) | 2010-07-28 |
US7417049B2 (en) | 2008-08-26 |
MXPA04010191A (es) | 2005-02-03 |
EP1499618A1 (en) | 2005-01-26 |
NO20044996L (no) | 2005-01-18 |
EP1499618B1 (en) | 2010-10-13 |
WO2003087102A1 (en) | 2003-10-23 |
AU2003225456B2 (en) | 2009-02-05 |
US20050176745A1 (en) | 2005-08-11 |
CA2482311A1 (en) | 2003-10-23 |
CA2482311C (en) | 2009-12-08 |
BR0309343A (pt) | 2005-02-15 |
IL164509A0 (en) | 2005-12-18 |
ATE484508T1 (de) | 2010-10-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1079519A1 (en) | Furyl compounds | |
HK1079522A1 (en) | Thienyl compounds | |
HK1080470A1 (en) | Heterocyclic compounds | |
PL372926A1 (en) | Piperidine-pyridazones and phthalazones as pde4 inhibitors | |
SE0202463D0 (sv) | Novel compounds | |
SE0401971D0 (sv) | Piperidne derivatives | |
PH12013500123A1 (en) | Hemiasterlin derivatives and uses thereof | |
WO2004062613A3 (en) | Hiv integrase inhibitors | |
TW200510325A (en) | 2-acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof | |
IL173810A0 (en) | Imidazopyridine derivatives and pharmaceutical compositions containing the same | |
SE0401970D0 (sv) | Novel compounds | |
WO2005021544A3 (en) | N3-substituted imidazopyridine-derivatives as c-kit inhibitors | |
DE60330651D1 (en) | C3-cyanoepothilonderivate | |
UA86776C2 (ru) | Производные бензимидазола, фармацевтическая композиция, которая их содержит, способ их получения и применение | |
SE0301320D0 (sv) | Positive modulators of nicotinic acetylcholine receptors | |
TW200626581A (en) | Compounds, compositions containing them, preparation thereof and uses thereof | |
SE0203070D0 (en) | Novel compounds | |
IL173809A0 (en) | Imidazopyridine derivatives and pharmaceutical compositions containing the same | |
SE0203303D0 (sv) | Novel Compounds | |
GB0229081D0 (en) | Multifunctional cationic photoinitiators, their preparation and use | |
EA200600992A1 (ru) | Амиды тиазолидинона, амиды тиазолидинкарбоновой кислоты, способы их получения и их применение | |
HK1091816A1 (en) | Diphenylurea derivatives and their use as chloride channel blockers | |
SE0300105D0 (sv) | Diarylmethylidene piperdine derivatives, preparations thereof and uses thereof | |
MXPA06007007A (es) | Derivados de prolina usados como ingredientes farmaceuticos activos para el tratamiento de tumores. | |
MY139228A (en) | Imidazolinylmethyl aralkylsulfonamides |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20130415 |